Molecular screening for Hepatitis virus

HBV can cause acute and chronic infection.There is currently no role for molecular testing in the diagnosis of acute hepatitis B other than in the detection of asymptomatic patients during pretransfusion screening of blood products. To facilitate an understanding of the utility of molecular testing for chronic hepatitis B, the four stages of chronic hepatitis B infection that are currently recognized, as well as an additional entity, occult hepatitis B, that can be diagnosed only by sensitive nucleic acid amplification methods, are reviewed in detail, including available therapeutic age

  • serological and molecular testing
  • Laboratory methods for diagnosis

Related Conference of Molecular screening for Hepatitis virus

November 16-17, 2020

30th World Congress on Nursing

Brisbane, Australia
November 18-19, 2020

3rd International Conference on Chemistry Education and Research

Singapore City, Singapore
November 23-24, 2020

World Conference on Digestive and Metabolic Diseases

Hanoi, Vietnam
December 03-04, 2020

11th International Conference on Liver Diseases & Hepatology

Singapore City, Singapore
December 07-08, 2020

International Congress on Gastroenterology and Liver Transplant

Auckland, Newzealand
April 12-13, 2021

16th Euro-Global Gastroenterology Conference

London, UK
May 07-08, 2021

International Conference on Gastroenterology and Liver

Amsterdam, Netherlands

Molecular screening for Hepatitis virus Conference Speakers

Recommended Sessions

Related Journals

Are you interested in